FIELD: biotechnology.
SUBSTANCE: invention relates to peptides with antibacterial activity, and can be used in medicine for the prevention or treatment of infectious diseases.
EFFECT: invention provides production of peptides effective in inhibiting the growth of gram-positive/gram-negative bacteria, which provides the necessary therapeutic effect in the treatment of sepsis.
35 cl, 6 dwg, 7 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBACTERIAL PEPTIDES | 2007 |
|
RU2468033C2 |
| PEPTIDE COMPOSITION FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE | 2021 |
|
RU2816119C1 |
| LYSINE POLYPEPTIDES ACTIVE AGAINST GRAM-NEGATIVE BACTERIA | 2016 |
|
RU2724545C2 |
| ANTIBIOTIC PEPTIDES | 2008 |
|
RU2472805C2 |
| BACTERIOPHAGE-DERIVED ANTIMICROBIAL POLYPEPTIDES AND THEIR USE AGAINST GRAM-NEGATIVE BACTERIA | 2019 |
|
RU2804774C2 |
| POLYPEPTIDE CONSTRUCTIONS LYSINE-ANTIMICROBIAL PEPTIDE (AMP), LYSINES, ISOLATED ENCODING POLYNUCLEOTIDES AND VARIANTS OF THEIR APPLICATION | 2019 |
|
RU2803121C2 |
| POLYPEPTIDES OR THEIR SALTS AND PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2083589C1 |
| NEW POLYPEPTIDE AND PHARMACEUTICAL COMPOSITION AGAINST HIV-INFECTION | 1994 |
|
RU2136696C1 |
| PEPTIDE WITH ANTIBACTERIAL ACTIVITY AGAINST MICROORGANISMS WITH MULTIDRUG RESISTANCE | 2021 |
|
RU2771493C1 |
| MODIFIED ENDOLYSIN AND ANTIBACTERIAL COMPOSITIONS BASED THEREON FOR TREATING INFECTIONS CAUSED BY ACINETOBACTER BAUMANNII, PSEUDOMONAS AERUGINOSA, KLEBSIELLA PNEUMONIAE, ESCHERICHIA COLI BACTERIA | 2023 |
|
RU2813626C1 |
